0001104659-20-122032.txt : 20201105 0001104659-20-122032.hdr.sgml : 20201105 20201105201448 ACCESSION NUMBER: 0001104659-20-122032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201103 FILED AS OF DATE: 20201105 DATE AS OF CHANGE: 20201105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lefenfeld Michael CENTRAL INDEX KEY: 0001826906 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 201292114 MAIL ADDRESS: STREET 1: IMMUNOME, INC. STREET 2: 665 STOCKTON DRIVE, SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 4 1 a4.xml 4 X0306 4 2020-11-03 0 0001472012 Immunome Inc. IMNM 0001826906 Lefenfeld Michael C/O IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 EXTON PA 19341 1 0 0 0 Stock Option (Right to Buy) 11.38 2020-11-03 4 A 0 7500 0 A 2030-11-03 Common Stock 7500 7500 D One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter. /s/ Richard F. Fitzgerald, Attorney-in-Fact 2020-11-05